Targeting PLK1 as a Common Mechanism in Ph-like ALL |
University of Texas M.D. Anderson Cancer Center / Joya Chandra, PhD |
Reach Grants |
2016 |
Texas |
DFMO Synergy with Chemo-immunotherapy to Eradicate MYC-Driven Neuroblastoma |
Children’s Hospital of Philadelphia / Michael Hogarty, MD |
Reach Grants |
2016 |
Pennsylvania |
LSD1 Inhibition to Treat T-cell Acute Lymphoblastic Leukemia/Lymphoma |
University of Virginia, School of Medicine / Michael Engel, MD/PhD |
Reach Grants |
2016 |
Virginia |
Engineering the CAR T Cells to Overcome Tumor Derived Immune-Inhibition in Glioblastoma |
Baylor College of Medicine / Meenakshi Hegde, MD |
'A' Award Grants |
2016 |
Texas |
Role of Primary Cilium Signaling and Dynamics in Medulloblastoma Initiation and Progression |
University of Texas Southwestern Medical Center / Saikat Mukhopadhyay, MD/PhD |
'A' Award Grants |
2016 |
Texas |
The Role of Inherited MLL3 Single Nucleotide Variants and Fetal Epigenetic Programming in Infant Leukemogenesis |
Washington University / Jeffrey Magee, MD/PhD |
'A' Award Grants |
2016 |
Missouri |
An Engineered Nanoimmunotherapy for Treating Neuroblastoma |
George Washington University / Rohan Fernandes, PhD |
'A' Award Grants |
2016 |
District of Columbia |
Uncovering the Dysregulated RNA Binding Protein Network in Childhood Acute Myeloid Leukemia |
Memorial Sloan-Kettering Cancer Center / Michael Kharas, PhD |
'A' Award Grants |
2016 |
New York |
Child's Exposure to Radiation from Medical Imaging and the Risk of Childhood Leukemia: Pooled Analyses from the Childhood Leukemia International Consortium (CLIC) |
University of California Berkeley / Catherine Metayer, MD/PhD & Steve Selvin, PhD |
Epidemiology Grants |
2016 |
California |
Sepsis as innate immune stimulus: severe sepsis exposures and protection against relapse in children with acute leukemias |
Children’s Hospital of Philadelphia / Alix Seif, MD |
Epidemiology Grants |
2016 |
Pennsylvania |